Aller au contenu principal
Nom officiel d’étiquetage de l’UEEntrée 16319 du glossaire

METHENAMINE

Cette fiche confirme une dénomination commune officielle d’ingrédient pour l’étiquetage des produits cosmétiques de l’UE. Elle ne confirme pas à elle seule que la substance est autorisée, non restreinte ou sûre.

Aperçu des preuves mondiales

L’identité résolue présente des preuves réglementaires correspondantes dans 7 des 13 jeux de données de marchés indexés : 6 fiches de pays et 1 fiches d’annexes de l’UE. Chaque résultat et chaque lacune de preuves sont énumérés ci-dessous.

7 marchés avec preuves
Marchés vérifiés
13
Marchés avec preuves
7
Lacunes de preuves
6
Identifiants résolus
2

Identité résolue de la substance

CAS:100-97-0
EC:202-905-8
Fiches de l’index des ingrédients :
METHENAMINE
Fonctions cosmétiques : ANTIMICROBIAL, PRESERVATIVE

1,3,5,7-Tetraazatricyclo[3.3.1.1(3,7)]decane

Note de restriction de l’inventaire : V/30

6 noms correspondants ou signalés
METHENAMINEmethenamineMethenamineHexamethylenetetramine (methenamine) (INN) CAS No. 100-97-0乌洛托品 — Methenamine (CAS No. 100-97-0)메텐아민(헥사메칠렌테트라아민)

Preuves réglementaires dans les 13 marchés

Ouvrez chaque fiche correspondante pour connaître son champ d’application, sa concentration, ses conditions, ses avertissements et la version de la source officielle.

Balayez ou faites défiler horizontalement pour voir la couverture des jeux de données et les actions suivantes.

MarchéRésultatFichesJeu de donnéesSignification / action suivante
European Union
EU
Correspondance de liste positive conditionnelle1Ouvrir la fiche 1
Complete annex dataset
Regulation (EC) 1223/2009 consolidated to 1 May 2026
Examinez chaque fiche associée et ses conditions exactes.
Great Britain
GB
Permitted list with conditions1Ouvrir la fiche 1
Complete consolidated annex dataset
GB retained Regulation 1223/2009 schedules, effective 15 August 2026
Examinez chaque fiche associée et ses conditions exactes.
Canada
CA
Aucune correspondance trouvée0
Complete Hotlist snapshot
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025
The Hotlist is an administrative compliance tool, not an exhaustive safety approval list.
New Zealand
NZ
Permitted list with conditions1Ouvrir la fiche 1
Complete schedules dataset
Cosmetic Products Group Standard schedules effective 1 January 2026
Examinez chaque fiche associée et ses conditions exactes.
ASEAN
ASEAN
Permitted list with conditions1Ouvrir la fiche 1
Complete regional annex dataset
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026
Examinez chaque fiche associée et ses conditions exactes.
China
CN
Prohibited1Ouvrir la fiche 1
Complete prohibited catalogues plus official-source workflow
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025
Examinez chaque fiche associée et ses conditions exactes.
Japan
JP
Aucune correspondance trouvée0
Complete Standards appendices dataset
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot
The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion.
South Korea
KR
Restricted1Ouvrir la fiche 1
Complete current appendix dataset
MFDS Notice 2026-19, effective 18 March 2026
Examinez chaque fiche associée et ses conditions exactes.
United States
US
Aucune correspondance trouvée0
Complete enumerated federal ingredient rules
eCFR Title 21 issue date 27 August 2026
FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety.
Australia
AU
Restricted1Ouvrir la fiche 1
Complete cosmetic-relevant Poisons Standard subset plus official workflow
Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
Examinez chaque fiche associée et ses conditions exactes.
Brazil
BR
Aucune correspondance trouvée0
Complete prohibited dataset plus current restricted-list workflow
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026
RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026.
India
IN
Aucune correspondance trouvée0
Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)
The standards are separate controlled publications; absence from a locally indexed excerpt is not permission.
Saudi Arabia
SA
Aucune correspondance trouvée0
Complete official list index
SFDA live prohibited/restricted lists, snapshot 30 August 2026
No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply.
Aucune ligne de marché ne correspond à ce filtre.

Fiches de marché correspondantes et conditions

Preuves exactes des annexes II à VI

Identité et propriétés chimiques

Structure chimique 2D PubChem pour le CAS 100-97-0
CAS 100-97-0PubChem CID 4101

Hexamethylenetetramine

Hexamethylenetetramine is a polycyclic cage that is adamantane in which the carbon atoms at positions 1, 3, 5 and 7 are replaced by nitrogen atoms. It has a role as an antibacterial drug. It is a polycyclic cage, a tetramine and a polyazaalkane. — ChEBI

Nom IUPAC
1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane
Formule moléculaire
C6H12N4
Masse moléculaire
140.19 g/mol
Masse exacte
140.106196400 Da
XLogP3
0,3
Surface polaire topologique
13,0 Ų
Donneurs de liaisons hydrogène
0
Accepteurs de liaisons hydrogène
4
Unités covalentes
1
Stéréocentres définis
0

Également connu sous le nom de

methenamineHexamineUrotropineUrotropin1,3,5,7-TetraazaadamantaneUritoneHMTAHexamethylenamine
16 autres noms signalés
FormamineHexamethylene tetramineMethenaminAmmoformCystaminCystogenAmmonioformaldehydeForminAceto HMTHexamethylenetetraamineAminoformaldehydePreparation AFAntihydralDuirexolHexaformMetenamina
Identifiants de bases de données externes

Preuves issues de bases de données scientifiques complémentaires

EMBL-EBI ChEBI
Correspondance exacte d’identifiantCHEBI:6824

hexamethylenetetramine

A polycyclic cage that is adamantane in which the carbon atoms at positions 1, 3, 5 and 7 are replaced by nitrogen atoms.

Formule
C6H12N4
Masse moyenne
140.190 g/mol
Masse monoisotopique
140.10620 Da
Charge formelle
0
  • polycyclic cage — is a (CHEBI:33640)
  • polyazaalkane — is a (CHEBI:39474)
  • tetramine — is a (CHEBI:39166)
  • antibacterial drug — has role (CHEBI:36047)
  • antibacterial agent — has role (CHEBI:33282)
  • antibacterial drug — has role (CHEBI:36047)
  • antibacterial agent — has role (CHEBI:33282)
  • polycyclic cage — is a (CHEBI:33640)
  • polyazaalkane — is a (CHEBI:39474)
  • tetramine — is a (CHEBI:39166)
Noms supplémentaires validés
1,3,5,7-tetraazaadamantane1,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]decaneAminoformE-239E239hexamethylenaminehexamethylene tetraminehexamethylenetetramineHexamethylentetraminhexamethylentetraminumhexaminehexaminumHMTHMTAINS-239INS NO.239methenamineNSC-26346NSC-403347
Références croisées de cette source
  • CAS: 100-97-0 — ChemIDplus
  • CAS: 100-97-0 — NIST Chemistry WebBook
  • REGISTRY_NUMBER: 2018 — Reaxys
  • REGISTRY_NUMBER: 26964 — Gmelin
  • MANUAL_X_REF: 3344 — DrugCentral
  • MANUAL_X_REF: D00393 — KEGG DRUG
  • MANUAL_X_REF: HMDB0029598 — HMDB
  • MANUAL_X_REF: LSM-5440 — LINCS
  • MANUAL_X_REF: Methenamine — Wikipedia
  • MANUAL_X_REF: US2762799 — Patent
  • MANUAL_X_REF: US2762800 — Patent

Mis en correspondance par: Exact CAS cross-reference in the ChEBI compound record. Source mise à jour le: 2017-02-22. Récupéré le: 2026-08-31. Ouvrir la fiche source

NIH PubChem PUG-View
Correspondance exacte d’identifiant4101

Attributed physical-property, hazard, environmental and use annotations.

  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) shou Source: CAMEO Chemicals
  • ERG2024, Guide 133 (Hexamethylenetetramine): General First Aid:; · Call 911 or emergency medical service.; · Ensure that medical personnel are aware of the material(s) involved, take precautions to protect themselves and avoid contamination.; · Move victim to fresh air if it can be done safely.; · Administer oxygen if breathing is difficult.; · If victim is not breathing:; -- DO NOT perform mouth-to-mouth resuscitation; the victim may have ingested or inhaled the substance.; -- If equipped and pulse detected, wash face and mouth, then give artificial respiration using a proper respiratory medical device (bag-valve mask, pocket mask equipped with a one-way valve or other device).; -- If no pulse detected or no respiratory medical device available, provide continuous compressions. Conduct a pulse check every two minutes or monitor for any signs of spontaneous respirations.; · Remove and isolate contaminated clothing and shoes.; · For minor skin contact, avoid spreading material on unaffected skin.; · In case of contact with substance, remove immediately by flushing skin or eyes with running water for at least 20 minutes.; · For severe burns, immediate medical attention is required.; · Effects of exposure (inhalation, ingestion, Source: Emergency Response Guidebook (ERG)
  • Signal: Warning Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • GHS Hazard Statements: H228: Flammable solid [Danger Flammable solids]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin] Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Precautionary Statement Codes: P210, P240, P241, P261, P272, P280, P302+P352, P321, P333+P317, P362+P364, P370+P378, and P501 (click each P-code to see the statement) Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Signal: Danger Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H228 (100%): Flammable solid [Danger Flammable solids]; H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin] Source: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P210, P240, P241, P261, P272, P280, P302+P352, P321, P333+P317, P362+P364, P370+P378, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 1051 reports by companies from 19 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]; H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]; H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H334 (100%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]; H351 (100%): Suspected of causing cancer [Warning Carcinogenicity] Source: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P233, P260, P261, P264, P270, P271, P272, P280, P284, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P318, P321, P330, P333+P317, P342+P316, P362+P364, P363, P403, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • Signal: Danger Source: NITE-CMC
  • GHS Hazard Statements: H228: Flammable solid [Danger Flammable solids]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H361: Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] Source: NITE-CMC
  • Cosmetic Ingredient Review Conclusion: On the basis of the animal and clinical data presented in this report, the CIR Expert Panel concludes that Methenamine is safe for cosmetic use at concentrations not to exceed 0.16% in formulation. It cannot be concluded that Methenamine is safe for use in cosmetic products intended to be aerosolized. Source: Cosmetic Ingredient Review (CIR)
  • Cosmetic Ingredient Review Finding(s): Safe for use in cosmetics, with qualifications Source: Cosmetic Ingredient Review (CIR)
  • Toxicity Summary: IDENTIFICATION AND USE: Methenamine is a white or colorless crystalline solid. It is an anti-infective agent. Methenamine hippurate tablets, USP are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. Non-medical uses include the following: in adhesives, coatings, and sealing compounds; as cross-linking agent for hardening phenol-formaldehyde resin and vulcanizing rubber; as corrosion inhibitor for steel; as fuel tablets for camping stoves; as stabilizer for lubricating and insulating oils; in the chemical detection of metals; in the preservation of hides; as dye fixative; for the manufacture of explosive compounds; antimicrobial food additive. HUMAN EXPOSURE AND TOXICITY: GI distress frequently is caused by doses >500 mg four times a day, even with enteric coated tablets. Painful and frequent micturition, albuminuria, hematuria, and rashes may result from doses of 4 to 8 g/day given for longer than 3-4 weeks. Inhalation may cause asthma-like reactions in previously sensitized individuals. Vapors or solutions have produced skin irritation. Methenamine does not appear to be linked to con Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Bioconcentration: An estimated BCF of 3 was calculated in fish for methenamine(SRC), using a log Kow of -2.18(1) and a regression-derived equation(2). According to a classification scheme(2), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC). Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 10(SRC), determined from a structure estimation method(2), indicates that methenamine is expected to have very high mobility in soil(SRC). The pKa of methenamine is 4.89(3), indicating that this compound will exist partially in cation form in the environment and cations generally adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(4). Volatilization of methenamine from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry's Law constant of 3.7X10-10 atm-cu m/mole(SRC), derived from its vapor pressure, 6.1X10-4 mm Hg(5), and water solubility, 3.02X10+5 mg/L(6). Methenamine is not expected to volatilize from dry soil surfaces based on its vapor pressure(SRC). Various biolodegradation screening studies have observed between 28-100% degradation of methenamine(7) suggesting that biodegradation is an important environmental fate process in soil(SRC). However, part (or most) of the degradation may be explained by hydrolysis to form formaldehyde and ammonia followed by biodegradation with the degradation rate increasing wi Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 10(SRC), determined from a structure estimation method(2), indicates that methenamine is not expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is not expected(3) based upon an estimated Henry's Law constant of 3.7X10-10 atm-cu m/mole(SRC), derived from its vapor pressure, 6.1X10-4 mm Hg(4), and water solubility, 3.02X10+5 mg/L(5). According to a classification scheme(6), an estimated BCF of 3(SRC), from its log Kow of -2.18(7) and a regression-derived equation(2), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Various biolodegradation screening studies have observed between 28-100% degradation of methenamine(8) suggesting that biodegradation is an important environmental fate process in soil(SRC). However, part (or most) of the degradation may be explained by hydrolysis to form formaldehyde and ammonia followed by biodegradation with the degradation rate increasing with acidity(8). Aqueous hydrolysis half-lives of 13.8 hours and 1.6 hours have been measured at 37.5 °C and pH 5.8 and pH 2 respectively(9). Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), methenamine, which has a vapor pressure of 6.1X10-4 mm Hg at 25 °C(2), will exist in both the vapor and particulate phases in the ambient atmosphere. Vapor-phase methenamine is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 45 minutes(SRC), calculated from its rate constant of 5.1X10-10 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Particulate-phase methenamine may be removed from the air by wet and dry deposition(SRC). Source: Hazardous Substances Data Bank (HSDB)
  • Industry Uses: Chemical reaction regulator; Monomers; Processing aids not otherwise specified; Binder; Other; Energy Releasers (explosives, motive propellant); Polymerization promoter; Terminator/Blocker; Processing aids, specific to petroleum production; Intermediate; Hardener; Adhesion/cohesion promoter; Not Known or Reasonably Ascertainable; Catalyst Source: EPA Chemical Data Reporting (CDR)
  • Cosmetic Ingredient Review Link: CIR ingredient: Methenamine Source: Cosmetic Ingredient Review (CIR)
  • Sources/Uses: Used in adhesives, coatings, sealants, and leather preservatives; also used as an anticorrosion agent, antibiotic, dye fixative, chemical stabilizer, and curing agent for formaldehyde resins and rubber; [HSDB] Used as a drug (methenamine) taken by mouth to prevent recurrent urinary tract infections; [Medscape DrugInfo] Used as a hardener for epoxy resins of the bisphenol A type; Used in the tire, rubber, foundry, and phenol-formaldehyde resin industries; Sometimes used in topical drugs and cosmetics; [Kanerva, p. 1811] Used as a formaldehyde releaser for photographic film development. [Kanerva, p. 1054-5] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
  • Industrial Processes with risk of exposure: Molding and Core Making [Category: Foundry]; Painting (Pigments, Binders, and Biocides) [Category: Paint]; Working with Glues and Adhesives [Category: Other]; Plastic Composites Manufacturing [Category: Industry]; Leather Tanning and Processing [Category: Industry]; Photographic Processing [Category: Other] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
  • Uses: Anti-Infective Agents, Urinary Source: Hazardous Substances Data Bank (HSDB)
  • Uses: For methenamine (USEPA/OPP Pesticide Code: 045501) there are 0 labels match. /SRP: Not registered for current use in the U.S., but approved pesticide uses may change periodically and so federal, state and local authorities must be consulted for currently approved uses./ Source: Hazardous Substances Data Bank (HSDB)
  • Uses: HMTA is used in the rubber industry to prevent vulcanized rubber from blocking and as a accelerator, as a curing agent for thermosetting resins (particularly phenyl-formaldehyde and urea-formaldehyde resins; in foundry mold castings as part of binder resins, in the production of nitrilotriacetic acid; in the manufacture of adhesives and coatings; in firelogs and briquettes for camping; and in flame-retardent materials. Because of its unique ability to hydrolyze to formaldehyde and ammonia under acidic conditions, it is also used in pharmaceuticals, for intestinal infection, and as a preservative in the food industry. Source: Hazardous Substances Data Bank (HSDB)
  • Uses: In adhesives, coatings, and sealing compounds; as cross-linking agent for hardening phenol-formaldehyde resin and vulcanizing rubber; as corrosion inhibitor for steel; as fuel tablets for camping stoves; as stabilizer for lubricating and insulating oils; in the chemical detection of metals; in the preservation of hides; as dye fixative; for the manufacture of explosive compounds; antimicrobial food additive; detection of metals. Source: Hazardous Substances Data Bank (HSDB)
  • Uses: For more Uses (Complete) data for METHENAMINE (9 total), please visit the HSDB record page. Source: Hazardous Substances Data Bank (HSDB)
  • Uses: Use (kg; approx.) in Germany (2009): >500; Use (kg; exact) in Germany (2009): 670; Consumption (g per capita; approx.) in Germany (2009): 0.00611; Consumption (g per capita; exact) in Germany (2009): 0.00818; Calculated removal (%): 8.8 Source: NORMAN Suspect List Exchange

Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source

Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.

Couverture des sources complémentaires et état des correspondances
SourceRésultatVérifié
EMBL-EBI ChEBICorrespondance exacte2026-08-31
NIH PubChem PUG-ViewCorrespondance exacte2026-08-31

Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.

Récupéré depuis NIH PubChem le 2026-09-02 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.

Recherche complémentaire sur la substance auprès de sources faisant autorité

Chaque lien lance une recherche de cette identité dans la source concernée. Un lien est une piste de recherche, et non l’affirmation que la source détient une fiche exacte. Ce qu’est chaque source et sa valeur juridique

Aller plus loin avec cette fiche

Analyser dans une formuleOuvrir la comparaison autonome

Source officielle et champ d’application

Importé de la décision d’exécution (UE) 2025/1175 de la Commission (version du jeu de données EU 2025/1175). Le glossaire fournit les dénominations communes des ingrédients pour la liste d’ingrédients exigée par l’article 19, paragraphe 1, point g) ; ce n’est ni une liste d’autorisation ni une liste de sécurité.

Ouvrir la décision officielle